Altria Group, Inc. logo

Altria Group, Inc. (MO)

Market Closed
5 Jun, 20:00
NYSE NYSE
$
72. 19
+1.59
+2.2521%
$
120.55B Market Cap
8.52 P/E Ratio
4.24% Div Yield
8.04M Volume
4.95 Eps
$ 70.6
Previous Close
Add Transaction
Day Range
71.19 73.18
Year Range
54.7 74.56
Want to track MO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Altria With 9% Dividend Yield - Because America Was Built On Tobacco

Altria With 9% Dividend Yield - Because America Was Built On Tobacco

Smoking causes cardiovascular diseases, even with minimal cigarette consumption. Nonetheless, its production has played a major role in America's history. Since 2005 Altria's stock performance has outperformed the S&P 500 but has stagnated since 2017. Altria's strategic shift towards e-vapor products and strong dividends make it a compelling option for income-focused investors.

Seekingalpha | 1 year ago
Better High-Yield Dividend Stock to Buy Now: AT&T vs. Altria Group

Better High-Yield Dividend Stock to Buy Now: AT&T vs. Altria Group

A pair of companies that have been paying dividends for decades offer yields above 6% at recent prices. AT&T's telephone business is down, but its broadband internet services keep offsetting the losses.

Fool | 1 year ago
Ex-Dividend Reminder: Coca-Cola, Altria Group And Meta Platforms

Ex-Dividend Reminder: Coca-Cola, Altria Group And Meta Platforms

On 6/14/24, Coca-Cola, Altria Group, and Meta Platforms will all trade ex-dividend for their respective upcoming dividends. Coca-Cola will pay its quarterly dividend of $0.485 on 7/1/24, Altria Group will pay its quarterly dividend of $0.98 on 7/10/24, and Meta Platforms will pay its quarterly dividend of $0.50 on 6/26/24.

Forbes | 1 year ago
Investors Heavily Search Altria Group, Inc. (MO): Here is What You Need to Know

Investors Heavily Search Altria Group, Inc. (MO): Here is What You Need to Know

Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 1 year ago
Is It Too Late to Buy Altria Group Stock?

Is It Too Late to Buy Altria Group Stock?

Altria spent years unwinding a high valuation that imploded with its Juul investment. The dividend remains the crown jewel.

Fool | 1 year ago
Juul E-Cigarette Ban Reversed Pending FDA Review

Juul E-Cigarette Ban Reversed Pending FDA Review

The jury is still out on the safety of the chemical additives that go into the popular devices.

Cnet | 1 year ago
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Altria Stock

Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Altria Stock

Altria currently offers an 8.4% dividend yield. The company is struggling against significant headwinds for cigarette sales.

Fool | 1 year ago
Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Walgreens Boots Alliance cut its dividend earlier this year, but even with the new payout, its yield remains high. Altria faces a challenging road ahead as tobacco use declines, but the company's dividend still looks safe right now.

Fool | 1 year ago
Juul e-cigarettes back under FDA review after marketing ban lifted

Juul e-cigarettes back under FDA review after marketing ban lifted

The US Food and Drug Administration (FDA) is rescinding an order that blocked the sale of Juul's products, including its e-cigarettes. The FDA in June 2022 banned all of Juul's products in the US, including the Juul device and four types of flavored Juul pods, on the basis that there was not sufficient evidence the marketing of the products would be appropriate for the protection of public health.

Proactiveinvestors | 2 years ago
Juul e-cigarettes' FDA ban lifted

Juul e-cigarettes' FDA ban lifted

The U.S. Food and Drug Administration said Thursday that it has rescinded its 2022 orders blocking the marketing of Juul Labs Inc.'s e-cigarette products in the U.S.

Marketwatch | 2 years ago
FDA Rescinds Ban On Juul E-Cigarettes

FDA Rescinds Ban On Juul E-Cigarettes

The Food and Drug Administration rescinded its ban on Juul Lab's e-cigarette products Thursday—placing them back under scientific review—nearly two years after ordering a ban that was halted pending the company's appeal.

Forbes | 2 years ago
US FDA rescinds market denial order for Juul products

US FDA rescinds market denial order for Juul products

The U.S. Food and Drug Administration (FDA) said on Thursday it was rescinding a June 2022 order that briefly blocked sale of Juul's products, including its device for e-cigarettes.

Reuters | 2 years ago
Loading...
Load More